Atrial Fibrillation Clinical Trials in Oklahoma City, Oklahoma
7 recruitingOklahoma City, Oklahoma
Showing 1–7 of 7 trials
Recruiting
Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Atrial Fibrillation
Johns Hopkins University5,350 enrolled91 locationsNCT05836987
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 3
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled184 locationsNCT03907046
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
Persistent Atrial FibrillationParoxysmal Atrial Fibrillation
Heart Rhythm Clinical and Research Solutions, LLC15,000 enrolled66 locationsNCT04088071
Recruiting
Phase 3
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
Diabetes MellitusAtrial Fibrillation
University of Oklahoma28 enrolled1 locationNCT05174052
Recruiting
Phase 1
Synaptic Plasticity in the Epicardial Ganglionated Plexi
Atrial Fibrillation
University of Oklahoma90 enrolled1 locationNCT05034419
Recruiting
Not Applicable
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
Paroxysmal Atrial Fibrillation
University of Oklahoma160 enrolled1 locationNCT05172765